Life Sciences Archives - Page 11 of 17 - Becker's Hospital Review

CareFirst sues J&J | Biotech co. lays off 15% of staff | AstraZeneca to buy vaccine co. for $1.1B | Bristol Myers scraps cancer drug trial | 13 of 20 most popular drugs in shortage

December 20, 2023 BHR Newsletter 1. CareFirst sues J&J over alleged anticompetitive biosimilar tactics Full story 2. CAOs: A growing C-suite fixture Full story 3. Biotech company lays off 15% of staff Full story 4. 2 hospitals are transforming care…

Biotech CEO pleads guilty to fraud scheme | US' 1st CRISPR gene therapy to treat sickle cell approved | Moderna exec steps down | Eli Lilly obesity drug hits shelves | Pfizer donates rights to cancer drug

December 13, 2023 BHR Newsletter 1. Biotech CEO pleads guilty to fraud scheme Full story 2. The layoff runway lengthens Full story 3. FDA approves nation's 1st CRISPR gene therapy to treat sickle cell disease: Experts react Full story 4.…

3 patients die in drug trial | Intermountain's biotech spinoff snags $10M | Pfizer exits BIO | The Mark Cuban effect on drug pricing | Eli Lilly blood cancer drug gains approval

December 6, 2023 BHR Newsletter 1. Intermountain's biotech spinoff raises $10M Full story 2. 15 top health systems, per Fortune + Premier Full story 3. 3 patients die in cancer drug trial Full story 4. Virtual nursing — why and…

Eli Lilly opens space for healthcare startups | 3 biotech co. layoffs | AstraZeneca dives into digital health | Exela Pharma recalls 400K drugs | 1st desmoid tumor drug approved

November 29, 2023 BHR Newsletter 1. Eli Lilly creates space for San Diego healthcare startups Full story 2. States with the most rural hospital closures Full story 3. 3 biotech companies laying off workers Full story 4. Successful AI initiatives…

Timber Pharmaceuticals files for bankruptcy | Surgeons raise concerns about Ozempic | FDA finalizes tougher rules for consumer drug ads | 6 drugs now in shortage

November 22, 2023 BHR Newsletter 1. Timber Pharmaceuticals files for bankruptcy Full story 2. The disease at the center of the $261M Johns Hopkins verdict Full story 3. Surgeons raise concerns about Ozempic, other GLP-1s Full story 4. Data silos are impeding efforts to advance cancer care.…

Thermo Fisher Scientific to close Ala. plant, lay off 97 workers | Wegovy cuts risk of major heart events: Study | What 5 hospitals pay their Epic talent | 1st Chikungunya virus vaccine approved

November 15, 2023 BHR Newsletter 1. Thermo Fisher Scientific to close Alabama plant, lay off 97 workers Full story 2. What 5 hospitals pay their Epic talent Full story 3. 'This will change prescribing practices': Wegovy cuts risk of major…

Sangamo Therapeutics cuts 40% of workforce | Cancer drug trial on hold | Amazon launches One Medical for Prime | FDA probes hospitalizations tied to fake Ozempic | Drug study sees 'unprecedented' results

November 8, 2023 BHR Newsletter 1. Biotech company lays off 40% of workforce, closes headquarters Full story 2. Amazon launches One Medical for Prime Full story 3. FDA probes hospitalizations tied to fake Ozempic Full story 4. Disjointed legacy data…

Professor's Alzheimer's drug research paused amid investigation | Pfizer to close NJ site, relocate nearly 800 workers | CVS, Walgreens walkouts may include 4,500 | Danaher taps biotech exec

November 1, 2023 BHR Newsletter 1. CUNY halts professor's Alzheimer's drug research amid investigation Full story 2. An estimated 4,500 participating in CVS, Walgreens walkouts: 5 updates Full story 3. Pfizer to close New Jersey site, relocate nearly 800…

Drugmaker to lay off 100+ post Biogen acquisition | Roche to buy drugmaker from Pfizer, Roivant for $7B | Moderna partners with Caris Life Science | J&J dengue pill shows promise | AI drugs' hype wears off

October 25, 2023 BHR Newsletter 1. Drugmaker to lay off 100+ after Biogen acquisition Full story 2. How Epic won over academic medical centers Full story 3. Roche to buy autoimmune drugmaker from Pfizer, Roivant for $7B Full story…

Alzheimer's drug researcher accused of 'egregious misconduct' | Investment firm buys minority stake in Catalio | Walgreens, CVS workers plan strike | Paxlovid popularity dwindles

October 18, 2023 BHR Newsletter 1. Alzheimer's drug researcher accused of 'egregious misconduct' Full story 2. Hospitals sour on Medicare Advantage: 8 things to know Full story 3. Investment firm buys minority stake in Catalio Full story 4. Do…